Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer

NCT06942416 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer
Neoplasm Recurrence, Local
Oligometastatic

Interventions

DRUG: Paclitaxel and Cisplatin/ Carboplatin
DRUG: Iparomlimab and Tuvonralimab
RADIATION: Radiotherapy

Sponsor

Shandong Cancer Hospital and Institute